Development and validation of a high-quality composite real-world mortality endpoint Published June 2018 Citation Curtis, M.D., Griffith, S.D., Tucker, M, Taylor, M.D., Capra, W.B., Carrigan, G, Holzman, B, Torres, A.Z., You, P, Arnieri, B, Abernethy, A.P. . Academy Health Annual Research Meeting. . https://4076230.fs1.hubspotusercontent-na1.net/hubfs/4076230/flatiron-com-pdf/FH_AH_2018_poster_final.pdf Authors: Sources:Academy Health Annual Research Meeting Share Posted inPublicationsMethodology More publicationsMedical Decision MakingApril 2026Using regression discontinuity in time to strengthen real-world evidence: a case study in lung cancerChen NC, Zemplenyi AT, Adamson B, et al.Publication summaryPublicationsMethodologyNon-small cell lung cancerISPORApril 2026Evaluating model performance for between-country survival transportabilityAli MS, Pittell H, Horne E, Mpofu P, Zhang Q, Adamson B, et al.Publication summaryPublicationsMethodologyMultiple myelomaClinical Pharmacology & Therapeutics January 2026Emulating comparative oncology trials with real-world evidence studies (ENCORE): Process development and methodological considerations for oncology real-world dataWeberpals J, Schneeweiss S, Kehl K, et al. Publication summaryPublicationsMethodology